Turner JH, et al. Cancer Biother. Radiopharm. (2003) cited as Ref 550 in DOI: 10.1038/s41392-020-0110-5 (Q9813)

From Wikibase.slis.ua.edu
Revision as of 15:45, 21 May 2020 by Admin (talk | contribs) (‎Created claim: Property:P105: 513-524, #quickstatements; #temporary_batch_1590074839150)
Jump to navigation Jump to search
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Turner JH, et al. Cancer Biother. Radiopharm. (2003) cited as Ref 550 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    Turner JH
    0 references
    Martindale AA
    0 references
    Boucek J
    0 references
    0 references
    2003
    0 references
    Cancer Biother. Radiopharm.
    0 references
    18
    0 references
    131I-anti CD20 radioimmunotherapy of relapsed or refractory non-Hodgkins lymphoma: a phase II clinical trial of a nonmyeloablative dose regimen of chimeric rituximab radiolabeled in a hospital (English)
    0 references
    513-524
    0 references